We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 467

How SUPPORT Will Affect Pharma Interactions With DEA
  • Cadwalader Wickersham & Taft LLP
  • USA
  • October 31 2018

The opioid package President Donald Trump signed last week garnered much attention. While it is largely directed at treatment and prevention, it


Considerations for Practicing Telemedicine in Ohio
  • Thompson Hine LLP
  • USA
  • October 29 2018

Telemedicine services are rapidly becoming more common in the United States due to their convenience and ability to increase access to care, expand


Upcoming INSPECT Compliance Dates
  • Krieg DeVault
  • USA
  • October 29 2018

Governor Eric Holcomb signed Senate Enrolled Act 221 (“SEA 221”) into law on March 22, 2018, which updated INSPECT requirements for practitioners


SUPPORT Act Expands Telehealth Treatment for Substance Use Disorders
  • Dinsmore & Shohl LLP
  • USA
  • October 25 2018

In a rare bipartisan and bicameral compromise, Congress has passed the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment


DEA to Propose Significant Regulatory Changes in the Coming Year
  • Quarles & Brady LLP
  • USA
  • October 23 2018

The Department of Justice recently published its list of proposed regulatory actions for the near and long term. It appears that the Drug Enforcement


“Did You Roll That Yourself?”: Travelling Tips Now that Cannabis is Legal in Canada
  • Field Law
  • USA, Canada
  • October 18 2018

Today’s the day! Cannabis has become legal in Canada for adult use, possession, purchase and distribution. As an important reminder, it remains


High time for clarification on cannabis advertising in Canada
  • Gowling WLG
  • Canada
  • October 15 2018

Cannabis is currently regulated as a "controlled substance" and "narcotic" (pre-October 17, 2018). The Narcotic Control Regulations prohibit the


“Clarification” of Border Crossing Rules Raises More Questions for Canadian Cannabis Industry
  • Wilson Elser
  • Canada
  • October 15 2018

U.S. Customs and Border Protection (CBP) clarified on October 9, 2018, that Canadians who work in Canada’s legal cannabis industry may enter the


Avoiding medical board discipline when prescribing opiates
  • Nossaman LLP
  • USA
  • September 10 2018

There is a host of new, ever changing, and conflicting guidelines from a multitude of regulators and academic societies. This evolving and uncertain


Mandatory CURES use begins October 2, 2018
  • Nossaman LLP
  • USA
  • August 28 2018

Starting October 2, 2018, health care practitioners authorized to prescribe, order, administer, or furnish a controlled substance must query, or